Migraine Tip of the Month
/
Rapid self-rescue: injectable sumatriptan
Read MoreLatest News
Letter from the Editor
/
While management of headache always has suffered from a “supply/demand” problem, the ongoing pandemic has served to highlight and aggravate that imbalance. Given the prevalence of headache in our society—and the prevalence of migraine in particular—there are simply too many citizens in need of headache management but too few providers available to meet that need. Again, COVID-19 has served to highlight this mismatch.
Read MoreDoctor on Call: First Migraine Prescription
/
“I recently had a terrible experience trying my first prescription medication for migraine. Although I have had migraine since childhood, not until recently did I decide to go see a doctor for help and try something besides my usual recipe of Excedrin and lying down in a dark room.”
Read MoreOccipital Nerve Blocks: Miracle therapy or glorified placebo?
/
Over the past two decades, this author has performed occipital nerve blocks (ONBs) over 10,000 times for the treatment of headache. The patients receiving those blocks have been a varied lot, but most have had “cervicogenic headache“, a term surprisingly unpopular with a number of headache specialists but nevertheless adequate for its descriptive value if not its specificity.
Read MoreVestibular Migraine: Where Headache and Dizziness Intersect
/
Learn how migraine and “dizziness” may be clinically and biologically linked.
Read MoreMigraine Treatment of the Month, Nurtec ODT: Standing Out from the Crowd
/
Since May 2018, within a period of just under two years, seven new medications for migraine treatment have received FDA approval and are available for routine clinical use. Our “Migraine Treatment of the Month” features the newest of the seven: rimegepant (Nurtec ODT; Biohaven Pharmaceuticals).
Read MoreMigraine Tip of the Month
/
As has been stressed in previous issues, an effective treatment strategy cannot be developed in the absence of an accurate diagnosis and, in the case of migraine, an accurate assessment of the patient's migraine burden. In evaluating headache and assessing migraine burden, the healthcare provider depends almost entirely upon the history provided by the patient.
Read MoreOf What Good is Migraine?
/
Why has the process of natural selection not excised this particular portion of the human genome? Of what earthly good can migraine be to the individuals afflicted or to the community at large? As many as 12% of the general population is actively afflicted with the disorder. Why?
Read MoreThe Patient's Perspective
/
A 31-year-old female student describes her experience with migraine and Nurtec.
Read MoreLetter from the Editor
/
Within the period of only a few months, we have been challenged by profoundly stressful events that have influenced virtually every aspect of our day-to-day lives. The COVID-19 pandemic and the recent civil unrest have produced a pervasive sense of unease. The stress accompanying that unease impairs our ability to cope gracefully and healthfully with whatever obstacles we must face.
Read MoreShout-Out
/
For many of us, one of the consequences of the ongoing pandemic and associated "social distancing" has been a heightened appreciation of those merchants who continue to supply both our basic needs and those welcome extras that inject a bit of spice into day-to-day life. This would seem to be an especially good time to express gratitude to at least some of those merchants.
Read MoreWe're Open for Business!
/
The healthcare providers associated with the George Washington University Department of Neurology and its Headache Center have continued to see patients throughout the COVID-19 pandemic.
Read MoreHeadache History Questionnaire for Patients
/
Download and complete this headache questionnaire prior to visiting your doctor if you want to get the most out of your visit.
Read MoreGW Headache Center New Patient Questionnaire
/To assist in preparing for your first visit, review “Your First Visit to the Doctor: Maximizing the Benefit” in the Spring 2018 issue of this magazine.
In addition, we have a modified version of the new patient questionnaire that we utilize at the GW headache Center. Click below to download the form for your visit.
A Migraine Revolution! Understanding the New Migraine Therapies
/
There is currently occurring nothing short of a revolution in migraine therapeutics. Little had emerged in the way of new migraine medications since onabotulinumtoxinA (Botox) became available for the treatment of chronic migraine in 2010. Suddenly, starting with the appearance of erenumab (Aimovig) in May 2018, new therapies for migraine prevention and acute migraine treatment have been dropping in our laps like eggs from an especially ambitious hen.
Read MoreMigraine Myth of the Month
/
If you have a history of migraine and experience a change in the character or frequency of your headaches, you should be concerned that you have developed a brain tumor or another serious neurologic disorder.
Read MoreMigraine Treatment of the Month
/
With so many new therapies for migraine rapidly becoming available, it was difficult to pick one single therapy to highlight in this issue.
Read MoreTip of the Month
/
Our tips this month are drawn from that article and others in which we have attempted to correct common misconceptions about migraine.
Read More
